For: | Wang R, Leong RM. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: A review of the literature. World J Gastroenterol 2014; 20(27): 8783-8789 [PMID: 25083052 DOI: 10.3748/wjg.v20.i27.8783] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i27/8783.htm |
Number | Citing Articles |
1 |
Koji Tanaka, Toshimitsu Araki, Yuji Toiyama, Yoshiki Okita, Yasuhiko Mohri, Masato Kusunoki. Colitis-Associated Cancer. 2016; : 23 doi: 10.1007/978-4-431-55522-3_2
|
2 |
Saeed Azizi, Hussein Al-Rubaye, Mohammed Adil A. Turki, Muhammad R. Sameem Siddiqui, Arun P. Shanmuganandan, Bushra Ehsanullah, Ranjeet Brar, Al-Mutaz Abulafi. Detecting dysplasia using white light endoscopy or chromoendoscopy in ulcerative colitis patients without primary sclerosing cholangitis: A systematic review and meta-analysis. International Journal of Surgery 2018; 52: 180 doi: 10.1016/j.ijsu.2018.02.028
|
3 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígado. Gastroenterología y Hepatología 2019; 42(5): 316 doi: 10.1016/j.gastrohep.2019.02.004
|
4 |
Ruth Zhang, Gregory Y Lauwers, Won-Tak Choi. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2022; 16(12): 1825 doi: 10.1093/ecco-jcc/jjac090
|
5 |
Jennifer L Horsley-Silva, Elizabeth J Carey, Keith D Lindor. Advances in primary sclerosing cholangitis. The Lancet Gastroenterology & Hepatology 2016; 1(1): 68 doi: 10.1016/S2468-1253(16)30010-3
|
6 |
Fotios S. Fousekis, Konstantinos H. Katsanos, Vasileios I. Theopistos, Gerasimos Baltayiannis, Maria Kosmidou, Georgios Glantzounis, Leonidas Christou, Epameinondas V. Tsianos, Dimitrios K. Christodoulou. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0967-3
|
7 |
Neil Bharat Marya, James H Tabibian. Role of endoscopy in the management of primary sclerosing cholangitis. World Journal of Gastrointestinal Endoscopy 2019; 11(2): 84-94 doi: 10.4253/wjge.v11.i2.84
|
8 |
Linda K. Wanders, Teaco Kuiper, Ralf Kiesslich, John G. Karstensen, Rupert W. Leong, Evelien Dekker, Raf Bisschops. Limited applicability of chromoendoscopy-guided confocal laser endomicroscopy as daily-practice surveillance strategy in Crohn’s disease. Gastrointestinal Endoscopy 2016; 83(5): 966 doi: 10.1016/j.gie.2015.09.001
|
9 |
Roberta E. Rossi, Dario Conte, Sara Massironi. Primary sclerosing cholangitis associated with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(2): 123 doi: 10.1097/MEG.0000000000000532
|
10 |
Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp, Stefan G. Hübscher. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology 2021; 161(6): 1764 doi: 10.1053/j.gastro.2021.07.046
|
11 |
Sridhar Sundaram, Vaneet Jearth. Primary Sclerosing Cholangitis: A Clinical Update. European Medical Journal 2019; : 101 doi: 10.33590/emj/10313809
|
12 |
Nik Dekkers, Menso Westerouen van Meeteren, Ron Wolterbeek, Arantza Farina Sarasqueta, Wim Laleman, Akin Inderson, Bruno Desschans, Bart van Hoek, Kerem Sebib Korkmaz, Severine Vermeire, Jeroen Maljaars. Does mucosal inflammation drive recurrence of primary sclerosing cholangitis in liver transplantion recipients with ulcerative colitis?. Digestive and Liver Disease 2020; 52(5): 528 doi: 10.1016/j.dld.2020.02.006
|
13 |
Isabel Roitman, Anjali Mone, Arun Swaminath. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; : 171 doi: 10.1007/978-3-030-81780-0_7
|
14 |
Erik Lundqvist, Ida Hed Myrberg, Sol Erika Boman, Deborah Saraste, Caroline E. Weibull, Kalle Landerholm, Staffan Haapaniemi, Anna Martling, Pär Myrelid, Caroline Nordenvall. Autoimmune and Metabolic Diseases and the Risk of Early-Onset Colorectal Cancer, a Nationwide Nested Case–Control Study. Cancers 2023; 15(3): 688 doi: 10.3390/cancers15030688
|
15 |
Arthur Belle, Valérie Laurent, Lieven Pouillon, Cédric Baumann, Xavier Orry, Anthony Lopez, Hélène Rousseau, Jean-Pierre Bronowicki, Laurent Peyrin-Biroulet. Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease. Digestive and Liver Disease 2018; 50(10): 1012 doi: 10.1016/j.dld.2018.06.024
|
16 |
Ruth Zhang, Dongliang Wang, Gregory Y. Lauwers, Won-Tak Choi. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. American Journal of Surgical Pathology 2024; doi: 10.1097/PAS.0000000000002255
|
17 |
|
18 |
Hannah Gordon, Livia Biancone, Gionata Fiorino, Konstantinos H Katsanos, Uri Kopylov, Eman Al Sulais, Jordan E Axelrad, Karthiha Balendran, Johan Burisch, Lissy de Ridder, Lauranne Derikx, Pierre Ellul, Thomas Greuter, Marietta Iacucci, Caroline Di Jiang, Christina Kapizioni, Konstantinos Karmiris, Julien Kirchgesner, David Laharie, Triana Lobatón, Tamás Molnár, Nurulamin M Noor, Rohit Rao, Simone Saibeni, Michael Scharl, Stephan R Vavricka, Tim Raine. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies. Journal of Crohn's and Colitis 2023; 17(6): 827 doi: 10.1093/ecco-jcc/jjac187
|
19 |
Noa Krugliak Cleveland, David T. Rubin, John Hart, Christopher R. Weber, Katherine Meckel, Anthony L. Tran, Arthur S. Aelvoet, Isabella Pan, Alex Gonsalves, John Nick Gaetano, Kelli M. Williams, Kristen Wroblewski, Bana Jabri, Joel Pekow. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon. Clinical Gastroenterology and Hepatology 2018; 16(1): 68 doi: 10.1016/j.cgh.2017.07.023
|
20 |
Omar K. Jamil, Dustin Shaw, Zifeng Deng, Nicholas Dinardi, Natalie Fillman, Shivani Khanna, Noa Krugliak Cleveland, Atsushi Sakuraba, Christopher R. Weber, Russell D. Cohen, Sushila Dalal, Bana Jabri, David T. Rubin, Joel Pekow. Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231184985
|
21 |
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach. Gastroenterology Insights 2022; 14(1): 13 doi: 10.3390/gastroent14010002
|
22 |
Craig Lammert, Raj Vuppalanchi. Primary Sclerosing Cholangitis. 2017; : 153 doi: 10.1007/978-3-319-40908-5_12
|
23 |
Trine Folseraas, Kirsten Muri Boberg. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis. Clinics in Liver Disease 2016; 20(1): 79 doi: 10.1016/j.cld.2015.08.014
|
24 |
Joanne Skinner, Louis Peters, Tomas Partington, Ashley Barnabas. Cancer screening and diagnosis in primary sclerosing cholangitis. Gastrointestinal Nursing 2017; 15(Sup5): S23 doi: 10.12968/gasn.2017.15.Sup5.S23
|
25 |
Arif A. Arif, Daljeet Chahal, Gale K. Ladua, Eric Bhang, Bill Salh, Greg Rosenfeld, Jonathan M. Loree, Fergal Donnellan. Hereditary and Inflammatory Bowel Disease-Related Early Onset Colorectal Cancer Have Unique Characteristics and Clinical Course Compared with Sporadic Disease. Cancer Epidemiology, Biomarkers & Prevention 2021; 30(10): 1785 doi: 10.1158/1055-9965.EPI-21-0507
|
26 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation. Gastroenterología y Hepatología (English Edition) 2019; 42(5): 316 doi: 10.1016/j.gastre.2019.02.030
|
27 |
Saira A. Khaderi, Norman L. Sussman. Screening for Malignancy in Primary Sclerosing Cholangitis (PSC). Current Gastroenterology Reports 2015; 17(4) doi: 10.1007/s11894-015-0438-0
|
28 |
Lukáš Bajer, Pavel Wohl, Pavel Drastich. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis. Vnitřní lékařství 2018; 64(6): 659 doi: 10.36290/vnl.2018.090
|
29 |
Jing‐Yuan Fang, Yong Quan Shi, Ying Xuan Chen, Jing Nan Li, Jian Qiu Sheng. Chinese consensus on the prevention of colorectal cancer (2016, Shanghai). Journal of Digestive Diseases 2017; 18(2): 63 doi: 10.1111/1751-2980.12450
|
30 |
Takahiro Miyazu, Natsuki Ishida, Yusuke Asai, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Satoshi Baba, Ken Sugimoto. Intrahepatic cholangiocarcinoma in patients with primary sclerosing cholangitis and ulcerative colitis: Two case reports. World Journal of Gastrointestinal Surgery 2023; 15(6): 1224-1231 doi: 10.4240/wjgs.v15.i6.1224
Abstract(231) |
Core Tip(361) |
Full Article(HTML)(1153)
|
Full Article with Cover (PDF)-10162K(54)
|
Full Article (Word)-5497K(29)
|
Audio-528K(3)
|
Peer-Review Report-274K(34)
|
Answering Reviewers-243K(39)
|
Full Article (PDF)-9751K(149)
|
Full Article (XML)-62K(38)
|
Times Cited (0)
|
Total Visits (3126)
|
Open
|
31 |
David M. Chascsa, Keith D. Lindor. Cancer risk, screening and surveillance in primary sclerosing cholangitis. Minerva Gastroenterologica e Dietologica 2019; 65(3) doi: 10.23736/S1121-421X.19.02586-8
|
32 |
Yuga Komaki, Fukiko Komaki, Dejan Micic, Akio Ido, Atsushi Sakuraba. Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis. Gastrointestinal Endoscopy 2017; 86(1): 93 doi: 10.1016/j.gie.2016.12.009
|
33 |
Jie Guo, Mengfan Liao, Jun Wang. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155. Cell Communication and Signaling 2021; 19(1) doi: 10.1186/s12964-021-00771-6
|
34 |
Nayantara Coelho-Prabhu, James D. Lewis. Update on Endoscopic Dysplasia Surveillance in Inflammatory Bowel Disease. American Journal of Gastroenterology 2023; 118(10): 1748 doi: 10.14309/ajg.0000000000002460
|
35 |
Manuela Cassotta, Danila Cianciosi, Rachele De Giuseppe, Maria Dolores Navarro-Hortal, Yasmany Armas Diaz, Tamara Yuliett Forbes-Hernández, Kilian Tutusaus Pifarre, Alina Eugenia Pascual Barrera, Giuseppe Grosso, Jianbo Xiao, Maurizio Battino, Francesca Giampieri. Possible role of nutrition in the prevention of inflammatory bowel disease–related colorectal cancer: A focus on human studies. Nutrition 2023; 110: 111980 doi: 10.1016/j.nut.2023.111980
|
36 |
Elif Sinem İPLİK, Resul KAHRAMAN, Barış ERTUĞRUL, Gonca CANDAN, Arzu ERGEN, Bedia ÇAKMAKOĞLU. The role of COX-2 gene variants on the disease mechanism of inflammatory bowel disease in a Turkish population. Archives of Clinical and Experimental Medicine 2018; 3(2): 45 doi: 10.25000/acem.416012
|
37 |
Jennifer L. Horsley‐Silva, Eduardo A. Rodriguez, Diana L. Franco, Keith D. Lindor. An update on cancer risk and surveillance in primary sclerosing cholangitis. Liver International 2017; 37(8): 1103 doi: 10.1111/liv.13354
|
38 |
Popescu Razvan Catalin, Leopa Nicoleta, Micu Luminita Gentiana, Costea Daniel Ovidiu, Olteanu Cornelia Minodora, Ciobanu Florin, Dumitru Andrei. Colon Cancer in Patients with Crohn’s Disease and Diabetes Mellitus. ARS Medica Tomitana 2020; 26(3): 150 doi: 10.2478/arsm-2020-0030
|
39 |
Rupert W.L. Leong, Jonathan Perry, Brayden Campbell, Jenn Koo, Ian B. Turner, Crispin Corte, Ian K. Fok. Knowledge and predictors of dysplasia surveillance performance in inflammatory bowel diseases in Australia. Gastrointestinal Endoscopy 2015; 82(4): 708 doi: 10.1016/j.gie.2015.04.004
|
40 |
Ming-Hsi Wang, Omar Y Mousa, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly C Cushing, Kelly Monroe, Billy D Nix, Rodney D Newberry, William A Faubion. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience. Inflammatory Bowel Diseases 2020; 26(5): 774 doi: 10.1093/ibd/izz209
|
41 |
F. Åberg, A. Abdulle, A. Mäkelä, M. Nissinen. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. Transplantation Proceedings 2015; 47(9): 2775 doi: 10.1016/j.transproceed.2015.09.043
|
42 |
Thomas Ryan, Jonathan P Segal. Liver outcomes following proctocolectomy in patients with primary sclerosing cholangitis and ulcerative colitis. Frontline Gastroenterology 2024; 15(4): 314 doi: 10.1136/flgastro-2023-102600
|
43 |
I.А. Hromakova, P.P. Sorochan, N.E. Prokhach, I.S. Hromakova. Interleukin-6 and colorectal cancer development. Український радіологічний та онкологічний журнал 2021; 29(4): 89 doi: 10.46879/ukroj.4.2021.89-107
|
44 |
Mohammad A. Sakr, Hend E. Ebada, Soheir Abdelkader, Hany M. Dabbous, Iman F. Montasser, Ahmed N. Bassuny, Yasmeen M. Massoud, Ahmed S. Abdelmoaty. Outcome of Colonoscopic Screening in Potential Liver Transplant Candidates. Transplantation Proceedings 2020; 52(1): 227 doi: 10.1016/j.transproceed.2019.10.026
|